PROSER3
gene geneOn this page
Also known as FLJ30657
Summary
PROSER3 (proline and serine rich 3, HGNC:25204) is a protein-coding gene on chromosome 19q13.12, encoding Proline and serine-rich protein 3 (Q2NL68).
Located in centrosome.
Source: NCBI Gene 148137 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_001367856
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25204 |
| Approved symbol | PROSER3 |
| Name | proline and serine rich 3 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ30657 |
| Ensembl gene | ENSG00000167595 |
| Ensembl biotype | protein_coding |
| Entrez | 148137 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 12 protein_coding, 3 protein_coding_CDS_not_defined, 3 nonsense_mediated_decay, 3 retained_intron
ENST00000301165, ENST00000396908, ENST00000421853, ENST00000444637, ENST00000536037, ENST00000536950, ENST00000537459, ENST00000539771, ENST00000542134, ENST00000542591, ENST00000544158, ENST00000544876, ENST00000545674, ENST00000600988, ENST00000601095, ENST00000620918, ENST00000646935, ENST00000696040, ENST00000696041, ENST00000696042, ENST00000696043
RefSeq mRNA: 11 — MANE Select: NM_001367856
NM_001039887, NM_001367856, NM_001395450, NM_001395451, NM_001395452, NM_001395453, NM_001395454, NM_001395455, NM_001395456, NM_001395457, NM_001395458
CCDS: CCDS46056, CCDS92595
Canonical transcript exons
ENST00000646935 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002209425 | 35767072 | 35768065 |
| ENSE00002317811 | 35762253 | 35762356 |
| ENSE00003585501 | 35762019 | 35762146 |
| ENSE00003965863 | 35759789 | 35759991 |
| ENSE00003965865 | 35759374 | 35759470 |
| ENSE00003965867 | 35758176 | 35758226 |
| ENSE00003965871 | 35768155 | 35768236 |
| ENSE00003965873 | 35764854 | 35764936 |
| ENSE00003965877 | 35766768 | 35766955 |
| ENSE00003965878 | 35765034 | 35765176 |
| ENSE00004282545 | 35768404 | 35771166 |
Expression profiles
Bgee: expression breadth ubiquitous, 174 present calls, max score 91.45.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.2353 / max 68.1138, expressed in 1763 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175401 | 8.5081 | 1751 |
| 208786 | 0.3553 | 153 |
| 175400 | 0.2208 | 66 |
| 175402 | 0.1511 | 52 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 91.45 | gold quality |
| right uterine tube | UBERON:0001302 | 90.73 | gold quality |
| left testis | UBERON:0004533 | 89.33 | gold quality |
| right testis | UBERON:0004534 | 89.08 | gold quality |
| sural nerve | UBERON:0015488 | 86.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 85.81 | gold quality |
| body of uterus | UBERON:0009853 | 85.29 | gold quality |
| testis | UBERON:0000473 | 85.13 | gold quality |
| right ovary | UBERON:0002118 | 85.11 | gold quality |
| left ovary | UBERON:0002119 | 84.89 | gold quality |
| left uterine tube | UBERON:0001303 | 84.81 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 84.51 | gold quality |
| colonic epithelium | UBERON:0000397 | 84.42 | gold quality |
| adenohypophysis | UBERON:0002196 | 84.26 | gold quality |
| metanephros cortex | UBERON:0010533 | 83.64 | gold quality |
| bone marrow cell | CL:0002092 | 83.48 | gold quality |
| endocervix | UBERON:0000458 | 83.46 | gold quality |
| ectocervix | UBERON:0012249 | 83.32 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 83.26 | gold quality |
| pituitary gland | UBERON:0000007 | 83.07 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 82.62 | gold quality |
| granulocyte | CL:0000094 | 82.33 | gold quality |
| ventricular zone | UBERON:0003053 | 82.23 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 82.20 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 82.14 | gold quality |
| lower esophagus | UBERON:0013473 | 82.13 | gold quality |
| tibial nerve | UBERON:0001323 | 81.72 | gold quality |
| thyroid gland | UBERON:0002046 | 81.67 | gold quality |
| body of stomach | UBERON:0001161 | 81.52 | gold quality |
| transverse colon | UBERON:0001157 | 81.50 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.34 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | proser3 | ENSDARG00000097591 |
| mus_musculus | Proser3 | ENSMUSG00000036864 |
| rattus_norvegicus | Proser3 | ENSRNOG00000024625 |
Protein
Protein identifiers
Proline and serine-rich protein 3 — Q2NL68 (reviewed: Q2NL68)
All UniProt accessions (12): A0A2R8Y8D9, A0A8Q3WKY3, A0A8Q3WKY6, A0A8Q3WKY7, C9JFW7, F5GXU6, F8W7U6, H0YFI8, M0QY86, M0QZ53, Q2NL68, S4R3L1
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q2NL68-1 | 1 | yes |
| Q2NL68-2 | 2 | |
| Q2NL68-3 | 3 | |
| Q2NL68-4 | 4 |
RefSeq proteins (11): NP_001034976, NP_001354785, NP_001382379, NP_001382380, NP_001382381, NP_001382382, NP_001382383, NP_001382384, NP_001382385, NP_001382386, NP_001382387 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037646 | PROSER3 | Family |
UniProt features (23 total): compositionally biased region 6, splice variant 6, region of interest 5, sequence variant 2, chain 1, modified residue 1, sequence conflict 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2NL68-F1 | 58.43 | 0.11 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 408
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 67 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN, WANG_CLIM2_TARGETS_UP, GCANCTGNY_MYOD_Q6, CAGCTG_AP4_Q5, GOCC_MICROTUBULE_ORGANIZING_CENTER, AACWWCAANK_UNKNOWN, AP1_Q4_01, GOCC_CENTROSOME, TGANTCA_AP1_C, CREB_Q3, RGAGGAARY_PU1_Q6, AGCYRWTTC_UNKNOWN, MARSON_BOUND_BY_E2F4_UNSTIMULATED, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, AP4_Q6_01
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): centrosome (GO:0005813), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
574 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PROSER3 | IQCC | Q4KMZ1 | 645 |
| PROSER3 | C19orf44 | Q9H6X5 | 614 |
| PROSER3 | TMEM139 | Q8IV31 | 528 |
| PROSER3 | GIGYF1 | O75420 | 501 |
| PROSER3 | CCDC9B | Q6ZUT6 | 480 |
| PROSER3 | PELI3 | Q8N2H9 | 479 |
| PROSER3 | LZTS2 | Q9BRK4 | 467 |
| PROSER3 | C10orf88 | Q9H8K7 | 430 |
| PROSER3 | CPAMD8 | Q8IZJ3 | 402 |
| PROSER3 | MRPS24 | P82668 | 399 |
| PROSER3 | DLGAP5 | Q15398 | 386 |
| PROSER3 | CFAP97 | Q9P2B7 | 386 |
| PROSER3 | ZZEF1 | O43149 | 385 |
| PROSER3 | ETNK2 | Q9NVF9 | 380 |
| PROSER3 | CCDC57 | Q2TAC2 | 377 |
IntAct
36 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PROSER3 | ZNF396 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PROSER3 | IQCC | psi-mi:“MI:0915”(physical association) | 0.560 |
| PROSER3 | SGF29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PROSER3 | NME7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PROSER3 | CCDC146 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PROSER3 | CCHCR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PROSER3 | CCDC57 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PROSER3 | CDC23 | psi-mi:“MI:0915”(physical association) | 0.560 |
| rep | SBNO1 | psi-mi:“MI:0914”(association) | 0.350 |
| MIF | BLTP3B | psi-mi:“MI:0914”(association) | 0.350 |
| CEP128 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP135 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| NINL | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ZNF396 | PROSER3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| IQCC | PROSER3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SGF29 | PROSER3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NME7 | PROSER3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCDC146 | PROSER3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCHCR1 | PROSER3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCDC57 | PROSER3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CDC23 | PROSER3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (23): PROSER3 (Proximity Label-MS), PROSER3 (Proximity Label-MS), PROSER3 (Proximity Label-MS), PROSER3 (Proximity Label-MS), PROSER3 (Proximity Label-MS), PROSER3 (Two-hybrid), PROSER3 (Two-hybrid), PROSER3 (Two-hybrid), PROSER3 (Two-hybrid), CCDC57 (Two-hybrid), CCDC101 (Two-hybrid), ZNF396 (Two-hybrid), CCHCR1 (Two-hybrid), PROSER3 (Proximity Label-MS), PROSER3 (Affinity Capture-MS)
ESM2 similar proteins: A0A096LP49, A0A8V8TNH8, A0A8V8TPE2, A2VE02, A5D7I0, A6NDY2, A6NGG8, A6NIJ5, A6NNJ1, A8MXJ8, A8MYA2, B1ASB6, B2RW88, D6RGX4, O60269, P0C7V4, P0C7W8, P0C7W9, P0C7X0, P0DV75, P0DV76, Q2KIS6, Q2NL68, Q3SY00, Q4R736, Q4V8B5, Q5RCQ2, Q5SZB4, Q5VZ46, Q5XIK6, Q658T7, Q66JV7, Q6NS69, Q6PAC4, Q6ZMY3, Q76N32, Q7TSA6, Q7Z591, Q80VW7, Q80X53
Diamond homologs: Q2NL68, Q7TSA6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 57 |
| Likely benign | 13 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1760 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:35762018:GGT:G | acceptor_gain | 1.0000 |
| 19:35762018:GGTAT:G | acceptor_gain | 1.0000 |
| 19:35766763:TACA:T | acceptor_loss | 1.0000 |
| 19:35766764:ACAGC:A | acceptor_loss | 1.0000 |
| 19:35766765:CA:C | acceptor_loss | 1.0000 |
| 19:35766766:A:AG | acceptor_gain | 1.0000 |
| 19:35766766:AGCAT:A | acceptor_loss | 1.0000 |
| 19:35766767:G:GG | acceptor_gain | 1.0000 |
| 19:35766767:GC:G | acceptor_gain | 1.0000 |
| 19:35766900:G:GT | donor_gain | 1.0000 |
| 19:35766900:G:T | donor_gain | 1.0000 |
| 19:35758224:CAGG:C | donor_loss | 0.9900 |
| 19:35758225:AGGTG:A | donor_loss | 0.9900 |
| 19:35758226:GGT:G | donor_loss | 0.9900 |
| 19:35758227:G:GC | donor_loss | 0.9900 |
| 19:35758228:T:A | donor_loss | 0.9900 |
| 19:35759372:A:AG | acceptor_gain | 0.9900 |
| 19:35759373:G:GG | acceptor_gain | 0.9900 |
| 19:35759780:T:A | acceptor_gain | 0.9900 |
| 19:35759787:A:AG | acceptor_gain | 0.9900 |
| 19:35759788:G:GG | acceptor_gain | 0.9900 |
| 19:35759987:GCCAA:G | donor_gain | 0.9900 |
| 19:35759988:CCAAG:C | donor_loss | 0.9900 |
| 19:35759990:AAG:A | donor_loss | 0.9900 |
| 19:35759991:AGTA:A | donor_loss | 0.9900 |
| 19:35759992:G:GG | donor_gain | 0.9900 |
| 19:35759992:G:T | donor_loss | 0.9900 |
| 19:35759993:T:A | donor_loss | 0.9900 |
| 19:35759994:AA:A | donor_loss | 0.9900 |
| 19:35762014:CACA:C | acceptor_loss | 0.9900 |
AlphaMissense
4594 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:35762032:T:C | F109L | 0.996 |
| 19:35762033:T:C | F109S | 0.996 |
| 19:35762034:C:A | F109L | 0.996 |
| 19:35762034:C:G | F109L | 0.996 |
| 19:35766868:G:C | W290C | 0.996 |
| 19:35766868:G:T | W290C | 0.996 |
| 19:35766866:T:A | W290R | 0.995 |
| 19:35766866:T:C | W290R | 0.995 |
| 19:35768172:T:C | F413L | 0.995 |
| 19:35768174:C:A | F413L | 0.995 |
| 19:35768174:C:G | F413L | 0.995 |
| 19:35768173:T:C | F413S | 0.990 |
| 19:35762033:T:G | F109C | 0.989 |
| 19:35762101:T:A | W132R | 0.988 |
| 19:35762101:T:C | W132R | 0.988 |
| 19:35766867:G:C | W290S | 0.985 |
| 19:35768173:T:G | F413C | 0.984 |
| 19:35766870:G:C | R291P | 0.981 |
| 19:35766879:G:C | R294P | 0.979 |
| 19:35762021:A:C | Y105S | 0.975 |
| 19:35762036:G:C | R110P | 0.975 |
| 19:35762103:G:C | W132C | 0.975 |
| 19:35762103:G:T | W132C | 0.975 |
| 19:35768182:A:G | D416G | 0.975 |
| 19:35762032:T:G | F109V | 0.974 |
| 19:35768191:T:C | L419P | 0.974 |
| 19:35766852:A:T | D285V | 0.973 |
| 19:35762020:T:G | Y105D | 0.972 |
| 19:35766858:T:A | L287Q | 0.969 |
| 19:35766855:T:C | I286T | 0.968 |
dbSNP variants (sampled 300 via entrez): RS1000309698 (19:35757631 T>C), RS1000338983 (19:35757363 CT>C), RS1000499931 (19:35759044 C>A,G,T), RS1000601652 (19:35771561 C>T), RS1000686022 (19:35766257 A>G), RS1000726103 (19:35758288 C>T), RS1001516589 (19:35768219 G>A,T), RS1001557310 (19:35757740 T>G), RS1001912609 (19:35769609 C>A,G,T), RS1002071043 (19:35764121 C>T), RS1002124267 (19:35762830 A>C,G), RS1002438245 (19:35771219 T>C,G), RS1002490209 (19:35767440 G>A), RS1002502974 (19:35756793 C>A,G), RS1002523005 (19:35767220 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010703_277 | Brain morphology (MOSTest) | 2.000000e-15 |
| GCST90000047_236 | Age at first sexual intercourse | 2.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
| EFO:0009749 | age at first sexual intercourse measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 3 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| dicrotophos | increases expression | 1 |
| bufotalin | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| beta-lapachone | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Zoledronic Acid | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Caffeine | increases phosphorylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Theophylline | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Acrylamide | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.